S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
pixel
pixel
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
pixel
pixel
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
pixel
pixel
S&P 500   3,853.07
DOW   31,176.01
QQQ   326.36
pixel
pixel
Log in
NYSE:HUM

Humana Stock Forecast, Price & News

$414.60
+3.26 (+0.79 %)
(As of 01/21/2021 12:00 AM ET)
Add
Compare
Today's Range
$410.49
Now: $414.60
$418.84
50-Day Range
$388.23
MA: $408.47
$447.69
52-Week Range
$208.25
Now: $414.60
$474.70
Volume864,075 shs
Average Volume1.10 million shs
Market Capitalization$54.87 billion
P/E Ratio13.29
Dividend Yield0.61%
Beta0.86
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; financial protection products; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE South Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2019, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. The company has a relationship with Cano Health, LLC to expand health centers in San Antonio and Las Vegas. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana logo

MarketRank

Overall MarketRank

2.47 out of 5 stars

Medical Sector

8th out of 1,926 stocks

Hospital & Medical Service Plans Industry

2nd out of 11 stocks

Analyst Opinion: 3.4Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 3.1 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
CUSIP44485910
Phone502-580-1000
Employees46,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$64.89 billion
Cash Flow$22.44 per share
Book Value$90.90 per share

Profitability

Net Income$2.71 billion

Miscellaneous

Market Cap$54.87 billion
Next Earnings Date2/3/2021 (Confirmed)
OptionableOptionable
$414.60
+3.26 (+0.79 %)
(As of 01/21/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Humana (NYSE:HUM) Frequently Asked Questions

How has Humana's stock price been impacted by COVID-19?

Humana's stock was trading at $328.22 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HUM stock has increased by 26.3% and is now trading at $414.60.
View which stocks have been most impacted by COVID-19
.

Is Humana a buy right now?

20 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 5 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Humana stock.
View analyst ratings for Humana
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Humana?

Wall Street analysts have given Humana a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Humana wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What is Larry J. Merlo's approval rating as Humana's CEO?

6,978 employees have rated Humana CEO Larry J. Merlo on Glassdoor.com. Larry J. Merlo has an approval rating of 37% among Humana's employees. This puts Larry J. Merlo in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

When is Humana's next earnings date?

Humana is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021.
View our earnings forecast for Humana
.

How can I listen to Humana's earnings call?

Humana will be holding an earnings conference call on Wednesday, February 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Humana's earnings last quarter?

Humana Inc. (NYSE:HUM) issued its quarterly earnings data on Tuesday, November, 3rd. The insurance provider reported $3.08 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.81 by $0.27. The insurance provider had revenue of $20.08 billion for the quarter, compared to analysts' expectations of $18.59 billion. Humana had a net margin of 5.58% and a return on equity of 22.74%. The firm's revenue for the quarter was up 23.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $5.03 earnings per share.
View Humana's earnings history
.

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Tuesday, November 3rd. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.625 per share on Friday, January 29th. This represents a $2.50 dividend on an annualized basis and a yield of 0.60%. The ex-dividend date of this dividend is Wednesday, December 30th.
View Humana's dividend history
.

Is Humana a good dividend stock?

Humana pays an annual dividend of $2.50 per share and currently has a dividend yield of 0.61%. Humana has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strock track record of dividend growth. The dividend payout ratio of Humana is 13.99%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Humana will have a dividend payout ratio of 11.50% next year. This indicates that Humana will be able to sustain or increase its dividend.
View Humana's dividend history.

What guidance has Humana issued on next quarter's earnings?

Humana updated its fourth quarter earnings guidance on Tuesday, January, 5th. The company provided earnings per share (EPS) guidance of ($2.40) for the period, compared to the Thomson Reuters consensus EPS estimate of ($2.37).

What price target have analysts set for HUM?

20 analysts have issued twelve-month target prices for Humana's stock. Their forecasts range from $406.00 to $510.00. On average, they anticipate Humana's share price to reach $459.43 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price.
View analysts' price targets for Humana
or view Wall Street analyst' top-rated stocks.

Are investors shorting Humana?

Humana saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 1,460,000 shares, a decline of 17.5% from the December 15th total of 1,770,000 shares. Based on an average trading volume of 766,000 shares, the days-to-cover ratio is presently 1.9 days. Currently, 1.1% of the company's stock are short sold.
View Humana's Short Interest
.

Who are some of Humana's key competitors?

What other stocks do shareholders of Humana own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), The Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA), The Boeing (BA), salesforce.com (CRM), Johnson & Johnson (JNJ) and JPMorgan Chase & Co. (JPM).

Who are Humana's key executives?

Humana's management team includes the following people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 59, Pay $5.43M)
  • Mr. Brian Andrew Kane, Chief Financial Officer (Age 48, Pay $2.12M)
  • Mr. Timothy S. Huval, Chief Admin. Officer (Age 55, Pay $1.8M)
  • Mr. T. Alan Wheatley, Segment Pres of Retail (Age 52, Pay $1.64M)
  • Dr. William Kevin Fleming Pharm.D., PharmD, RPh, Segment Pres of Clinical & Pharmacy Solutions (Age 53, Pay $1.5M)
  • Ms. Cynthia Hillebrand Zipperle, Sr. VP, Chief Accounting Officer & Controller (Age 58)
  • Mr. Sam M. Deshpande, Chief Technology & Risk Officer (Age 56)
  • Ms. Amy K. Smith, VP of Investor Relations
  • Mr. Joseph C. Ventura, Chief Legal Officer (Age 44)
  • Amy Fry, Sr. VP of Corp. Communications

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

Who are Humana's major shareholders?

Humana's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Ardevora Asset Management LLP (0.10%), Frontier Capital Management Co. LLC (0.07%), Wedge Capital Management L L P NC (0.05%), Rhenman & Partners Asset Management AB (0.04%), Baldwin Brothers Inc. MA (0.03%) and State of Alaska Department of Revenue (0.03%). Company insiders that own Humana stock include Brian P Leclaire, Christopher H Hunter, David A Jr/Ky Jones, Elizabeth D Bierbower, James J /Ky Obrien, Roy A Beveridge, Timothy Alan Wheatley and Timothy S Huval.
View institutional ownership trends for Humana
.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Frontier Capital Management Co. LLC, Hexavest Inc., Pendal Group Limited, Pacer Advisors Inc., Baldwin Brothers Inc. MA, Rhenman & Partners Asset Management AB, Smith Graham & Co. Investment Advisors LP, and MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH. Company insiders that have sold Humana company stock in the last year include David A Jr/Ky Jones, and Timothy S Huval.
View insider buying and selling activity for Humana
or view top insider-selling stocks.

Which institutional investors are buying Humana stock?

HUM stock was bought by a variety of institutional investors in the last quarter, including Ardevora Asset Management LLP, Journey Advisory Group LLC, Kestra Advisory Services LLC, Manning & Napier Group LLC, Wedge Capital Management L L P NC, IFM Investors Pty Ltd, Louisiana State Employees Retirement System, and Oxinas Partners Wealth Management LLC.
View insider buying and selling activity for Humana
or or view top insider-buying stocks.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $414.60.

How big of a company is Humana?

Humana has a market capitalization of $54.87 billion and generates $64.89 billion in revenue each year. The insurance provider earns $2.71 billion in net income (profit) each year or $17.87 on an earnings per share basis. Humana employs 46,000 workers across the globe.

What is Humana's official website?

The official website for Humana is www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000 or via email at [email protected]

This page was last updated on 1/22/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.